Google’s Biotech Venture Hit by Ethical Concerns over Deal with Luxury Clinic

April 7, 2016

(STAT News) – Andrew Conrad, who runs Google’s ambitious biotech offshoot, successfully pushed the company to award a research contract to a luxury health clinic he largely owns that has no documented experience with this kind of work, STAT has learned. The arrangement has stirred concern inside Verily Life Sciences — and among corporate governance experts who see it as a conflict of interest.